Share Name Share Symbol Market Type Share ISIN Share Description
BTG Plc LSE:BTG London Ordinary Share GB0001001592 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50p -0.09% 546.00p 545.00p 545.50p 548.00p 542.50p 546.00p 757,338 16:35:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 620.5 -70.6 3.9 140.0 2,114.74

BTG Share Discussion Threads

Showing 5851 to 5872 of 5875 messages
Chat Pages: 235  234  233  232  231  230  229  228  227  226  225  224  Older
DateSubjectAuthorDiscuss
16/10/2018
15:27
Downgrade by RBC. Price target 490.
dbford
16/10/2018
15:13
Thoughts on today’s fall against the background of positive Zytiga update? My guess probably the strengthening of sterling.
dp1umb
16/10/2018
14:42
From J&J statement according to Barclays: Sales of prostate cancer drug Zytiga surged ahead of analysts' estimates and raked in $958 million in the quarter, compared with the consensus estimate of $795 million. If the patent is extended this has got to be a takeover target.
gregsc
16/10/2018
14:04
I hate days like this!Value destruction by computers!
fhmktg
11/10/2018
13:38
A decent buy of 50k at 12.30- somebody is keeping the faith.In these troublesome times BTG continues to work to provide innovative treatments of immense potential to improve the experience of disease sufferers.Flying the flag for country.I might get frustrated at times, but I'm keeping faith as long as I can.The next 12_18 months could test our patience, but the growing cash flow is the key to a future dividend policy- it wouldn't surprise me for the incoming chair to bring that about.
fhmktg
11/10/2018
08:06
Hopefully, this news may temper the sea of red the rest of the market will no doubt see today.
cockneytrader
11/10/2018
07:13
So, BTG still acting for ICR on licences?
fhmktg
10/10/2018
17:56
dp1umb. You make a good point about things not being black or white. BTG have never liked to talk about EPS, only revenue. When asked, they will talk about commercial sensitivity. I would hazard a guess that without Zytiga and CroFab, BTG would be a significantly loss making company.
cockneytrader
10/10/2018
17:51
ICR no longer take half, as they sold part of their rights to private equity house. Do keep up.
cockneytrader
10/10/2018
17:45
And as you are well aware the patent expirey isn’t black and white.
dp1umb
10/10/2018
17:21
It's good to debate these items, that's what this forum is for.
cockneytrader
10/10/2018
17:19
BTG collect gross revenue, but are required to revenue share with ICR. Gross revenue is 6% plus multiplier. I assumed that you knew this.
cockneytrader
10/10/2018
16:56
How come last year J&J sales of Zytiga were ~ $2,524M, BTG income from Zytiga was $207.5M Income from Zytiga last year just under 10% at ~8%
dbford
10/10/2018
16:35
Dbford. I am not being rude, but I dislike incorrect assumptions based on no evidence whatsoever.
cockneytrader
10/10/2018
16:23
From discussions that I have had with management, BTG get 3% plus a multiplier based on sales. Search for ' BTG Zytiga 3% royalty '
cockneytrader
10/10/2018
16:16
Dbford. I can assure you that BTG do not get 10%. It is quite obvious from your statement that you haven't got the faintest idea what you are talking about.
cockneytrader
10/10/2018
16:04
CT, BTG gets about 10% revenue from sales of Zytiga. J&J 1st QR sales $909M, second QR sales likely to be higher than this. Thus good income from Zytiga. Yes, we dont know effect of generics next year, but reasonable sales likely to be maintained since Zytiga licenced for early use whereas competitors not yet.
dbford
10/10/2018
13:53
The 2019/20 calendar year for BTG quite honestly fill me with dread.
cockneytrader
10/10/2018
13:49
Zytiga has been a phenomenal success for both J&J and BTG. However, these royalties are under threat make no mistake. And going forward, the loss of these will impact the bottom line. $300m for 2018/19 is wishful thinking.
cockneytrader
10/10/2018
12:46
Dbford, so you are expecting $150m from Zytiga in 1st half - good luck with that!
cockneytrader
10/10/2018
00:37
Yes just imagine if we would of taken Zytiga all the way and not partnered it?
dp1umb
09/10/2018
23:32
J&J sales of Zytiga up >60% this year BTG income from Zytiga ~ $200M last year BTG income from Zytiga should be at least $300M this year
dbford
Chat Pages: 235  234  233  232  231  230  229  228  227  226  225  224  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20181017 17:53:05